Amgen

Amgen Challenges Novo Nordisk's Ozempic And Eli Lilly's Zepbound As Its Monthly Weight Loss Drug MariTide Enters Two Late-Stage Trials

FTC Takes A Rare Step Back, Pauses Legal Battle With Amgen Over $28B Horizon Deal

The Latest Picks And Pans From Barron's: Barrick Gold, BioNTech, Facebook, WW And More

FTC Takes A Rare Step Back, Pauses Legal Battle With Amgen Over $28B Horizon Deal

The Latest Picks And Pans From Barron's: Barrick Gold, BioNTech, Facebook, WW And More

Barron's Latest Picks And Pans: Apple, Coupang, GameStop, Uber, Walker & Dunlop And More

Benzinga's Bulls & Bears Of The Week: Altria, DowDupont, Oracle, Roku And More

Barron's Latest Picks And Pans: Apple, Coupang, GameStop, Uber, Walker & Dunlop And More

|

Benzinga's Bulls & Bears Of The Week: Altria, DowDupont, Oracle, Roku And More

|

Benzinga's Weekly Bulls & Bears: Amazon, Apple, GE, Twitter And More

|

Amgen's Repatha Results Not Good Enough For The Street

|

Amgen Recent News

Barron's Picks And Pans: Amgen, Barnes & Noble, Expedia And More

|

Barron's Picks And Pans: Best Dividend Stocks, Symantec, GoldCorp And More

|

Barron's: How To Find Safe 5% Yields

|

Barron's Picks And Pans: Monro Muffler Brake, Fidelity National Information Services And More

|

Biogen And Gilead Sciences Buck Biotech Short Interest Trend

|

Short Interest Surges In Illumina And Vertex Pharmaceuticals

|

Short Sellers Dump Vertex, Load Up On Baxalta

|

Big Biotech In The Earnings Spotlight

|

Radius Health's Overhangs Were Just Removed: Buy Time

|

Amgen, Celgene Buck Short Interest Trend In Biotech Stocks

|

Big Earnings Expectations For Big Biotech

|

More Wild Short Interest Swings In Biotech Stocks

|

Wild Short Interest Swings For Three Top Biotech Stocks

|

Wild Short Interest Swings For These Three Biotech Stocks

|

Akebia Therapeutics CEO On Controlling Anemia Safely

|

In Volatile Markets, Short Sellers Head For Biotechs

|

Large-Cap Biotechs Poised For Second-Half Rally, RBC Says

|

Biotech Short-Sellers Prefer Amgen To Gilead Sciences

|

Amgen, AstraZeneca End Development Pact; Shares Sink

|

Goldman Sachs Previews ASCO Cancer Conference With Amgen, Celgene And Clovis Oncology

|

Amgen Has A Big Launch Coming Up

|

Short Sellers Still Attracted To Biotech Stocks

|

Short Sellers Come Back To Biotech Stocks

|